#South Korea #Seongnam #hair health #LISCure #Mobiome

LISCure Biosciences: A Groundbreaking Milestone in Hair Health

LISCure Biosciences Inc., a trailblazer in biotechnology, announced a historic achievement in February 2025, when it received the first-ever regulatory approval from the Korean Ministry of Food and Drug Safety (KMFDS) for its innovative probiotic ingredient aimed at promoting hair health, known as Mobiome®. This pioneering milestone not only underscores LISCure’s advanced research and development but also positions the company at the forefront of a burgeoning market segment.

The Science Behind Mobiome®

Developed utilizing LISCure's proprietary technology, Mobiome® has shown remarkable efficacy in preclinical testing, highlighting its capacity to enhance antioxidant activity and display anti-inflammatory properties. Mechanistic studies have further illustrated its potential to stimulate the proliferation of follicular cells while effectively regulating their cell cycles.

Clinical trials involving human participants revealed statistically significant improvements in various hair-related metrics, including glossiness, elasticity, and overall satisfaction among users. Participants reported enhanced texture, reduced split ends, decreased dryness, and less tangling, establishing Mobiome® as a holistic solution for hair care (p<0.05, at a 95% confidence level).

Redefining Hair Care Solutions

Historically, consumers have had limited options for hair care, largely relegated to pharmaceuticals and topical products like shampoos. The introduction of Mobiome® signifies a broader regulatory expansion that is poised to invigorate the domestic and international hair health market. According to market analysis from Research and Markets, the global hair growth supplement industry is projected to surge, boasting a Compound Annual Growth Rate (CAGR) of 14.7% from 2023 to 2030, potentially reaching a staggering market value of $1.92 billion (approximately KRW 2.7 trillion) by 2030.

A Broader Vision for Health

LISCure isn't stopping at hair health; the company has its sights set on creating functional ingredients across various health sectors, including joint health, mental wellness, weight management, and kidney health. As part of their ambitious vision, LISCure is also advancing its global pharmaceutical initiatives. They have commenced patient dosing of LB-P8, a treatment for liver disease, which has received Investigational New Drug (IND) approval for Phase 2 clinical trials. The drug also holds Orphan Drug Designation and Fast Track Designation in the United States.

Moreover, LISCure is on a fast track for the joint commercialization of its innovative brain shuttle platform, Exo-Pass N, in partnership with global pharmaceutical leaders. The advancements in immuno-oncology therapies targeting colorectal and pancreatic cancers further showcase their commitment to pioneering solutions within the biopharmaceutical landscape.

Preparing for an IPO

With aspirations for an initial public offering (IPO) looming on the horizon, LISCure plans to leverage its promising global drug pipeline alongside the increasing revenue from its functional ingredient sector. By prioritizing both pharmaceutical R&D and technology licensing, LISCure aims to craft a stable, sustainable revenue model that will enhance its competitive stance on a global scale.

CEO's Vision

Hwa-Sup Chin, CEO of LISCure Biosciences, expressed his enthusiasm regarding this significant regulatory approval, stating, "Securing the world's first approval for a hair health probiotic is a monumental achievement in our R&D endeavors. We will continue to leverage our platform technologies to broaden our pipeline, extending beyond pharmaceuticals to include groundbreaking functional health ingredients. Our strategy revolves around optimizing the balance between licensing deals with major global pharmaceutical companies and sales of functional ingredients to bolster our competitiveness in the international market."

As LISCure Biosciences stands at the forefront of this innovative frontier, they are reshaping the landscape of health and beauty, presenting consumers with safe and effective solutions for hair health derived from the power of probiotics.